The Valley Desk

NCT04506905 · Interventional trial

Safety, Tolerability, and Pharmacokinetics Study of Elpipodect (MK-8189) in Participants With Schizophrenia and Healthy Participants (MK-8189-011)

Overall registry status Completed

Phase 1

Conditions Schizophrenia

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov